doi,title,pdf_path,route,ready_for_step6_text,paper_type,mentions_ibuprofen,mentions_diffusion_cell,franz_confirmed,where_diffusion_cell,where_franz,study_type,barrier_category,barrier_name_raw,endpoint_qfinal_found,endpoint_time_found,where_endpoint,figure_only,endpoint_carrier,endpoint_carrier_where,endpoint_carrier_snippet,formulation_carrier,formulation_carrier_where,formulation_carrier_snippet,endpoint_likely_in_supp,formulation_table_missing,notes
10.1002/14651858.cd001177.pub2,Topical agents or dressings for pain in venous leg ulcers.,GenAI\papers\pdf\10.1002_14651858.cd001177.pub2__6d7ce69484.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,Page 10,yes,narrative,"Page 10, Results section","""Two RCTs that described the use of ibuprofen as a topical agent in the form of a foam dressing that releases low-dose ibuprofen...""",unknown,,,no,no,The study references the use of ibuprofen foam dressing but lacks specific diffusion cell data.
10.1002/14651858.cd001177.pub3,Topical agents or dressings for pain in venous leg ulcers.,GenAI\papers\pdf\10.1002_14651858.cd001177.pub3__92afc39ccd.pdf,text,no,review,yes,no,no,unknown,unknown,IVPT,uncertain,unknown,yes,yes,Discussion,no,narrative,Discussion section of the review,Both trials reported that the between-group diﬀerence in pain relief assessment scores was statistically significant.,unknown,unknown,unknown,no,yes,"Ibuprofen is mentioned as part of foam dressings; however, no explicit mention of diffusion cell studies."
10.1002/etc.4302,Effects of skin region and relative lipophilicity on percutaneous absorption in the toad Rhinella marina.,GenAI\papers\pdf\10.1002_etc.4302__89ec992d2c.pdf,text,yes,primary_experiment,yes,yes,yes,PAGE 7,PAGE 7,IVPT,skin,Rhinella marina skin,yes,yes,PAGE 11,no,table_text,"PAGE 11, Table 3","Table 3 shows mean flux values for ibuprofen across skin types, along with statistical analyses.",table_text,"PAGE 7, Table 2",Table 2 details the validated HPLC methodologies and concentrations used for ibuprofen experiments in the study.,no,no,"This study investigates the permeation of ibuprofen through different skin regions of the terrestrial toad, utilizing Franz-type diffusion cells."
10.1002/open.202500038,Ibuprofen-Functionalized Alkyl α-hydroxy Methacrylate-Based Polymers.,GenAI\papers\pdf\10.1002_open.202500038__18833a3913.pdf,figure,no,primary_experiment,yes,yes,uncertain,Page 6,uncertain,IVPT,uncertain,uncertain,yes,yes,Page 6,no,figure,Figure 7 shows the cumulative IBU release from the prodrugs as a function of time.,Figure 7 shows cumulative release profiles of IBU from various prodrugs at different time intervals.,table_text,"Table 1 summarizes the solubility of TBMA-IBU and IBU as reference, in various solvents.","Table 1 summarizes solubility of TBMA-IBU and IBU in various solvents, indicating their physical properties.",no,no,
10.1007/978-1-4939-0363-4_7,Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.,GenAI\papers\pdf\10.1007_978-1-4939-0363-4_7__1f3c544b57.pdf,unknown,no,uncertain,no,no,no,,,uncertain,uncertain,,no,no,,no,unknown,,,unknown,,,no,uncertain,
10.1007/s11095-008-9785-y,Dermatopharmacokinetics: factors influencing drug clearance from the stratum corneum.,GenAI\papers\pdf\10.1007_s11095-008-9785-y__b257621dff.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,skin,stratum corneum,yes,yes,Table II,no,table_text,Table II,"Table II: Quantity of ibuprofen (mean ± SD, n=5) in the SC... noted here.",unknown,,,no,no,
10.1007/s11095-012-0939-6,Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles.,GenAI\papers\pdf\10.1007_s11095-012-0939-6__6f8de36d1e.pdf,figure,no,primary_experiment,yes,yes,yes,In vitro skin permeation studies on pig ear skin for 24 h under unocclusive conditions were performed as described previously.,The full thickness pig ear skin was mounted on Franz diffusion cells.,IVPT,skin,pig ear skin,yes,yes,Figure 3,no,figure,The amount of Ibu permeated into the receiver compartment after 24 h from NLC formulations is summarized in Figure 3A and from NPS formulations in Figure 3B.,"The amount of Ibu from Ibu-NLC-R11 permeated into the receiver compartment was 13.85 ± 0.82 μg/cm2. This amount was 4.3; 2.2 and 1.7 times higher than Ibu-Sol; Ibu-NLC and Ibu-NLC-YKA, respectively (Figure 3A).",unknown,The methodology does not specify a table or narrative detailing the formulations used.,"Various nanoparticle formulations including Ibu-NLC, Ibu-NLC-R11, Ibu-NLC-YKA, Ibu-NPS, Ibu-NPS-OA and Ibu-NPS+OA (PM) were applied on the diffusional surface of the skin.",no,uncertain,
10.1007/s11095-020-02887-9,Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems.,GenAI\papers\pdf\10.1007_s11095-020-02887-9__71e83a4015.pdf,text,yes,primary_experiment,yes,yes,yes,"Page 4, in vitro drug permeation using HFMN arrays","Page 4, modified Franz diffusion cells used in permeation assay",IVPT,skin,dermatomed neonatal porcine skin,yes,yes,"Page 5, the sample was subsequently centrifuged at 13,400 rpm for 15 min before quantification",no,narrative,Page 5,The amount of drug deposited on the skin surface was washed by applying 1 mL of PBS (pH 7.4)...,supplement,"Page 3, Materials section",Ibuprofen sodium (IBU Na) were obtained from Sigma-Aldrich...,no,no,
10.1007/s11095-024-03747-6,Fluorinated PAMAM-Arginine Carrier Prodrugs for pH-Sensitive Sustained Ibuprofen Delivery.,GenAI\papers\pdf\10.1007_s11095-024-03747-6__42a2bcfb6b.pdf,text,yes,primary_experiment,yes,yes,no,Page 4 - 'dialyzed against PBS for 130 h',unknown,IVPT,both,"dialysis membrane (SpectraPor® RC, MWCO = 1 kDa)",yes,yes,Page 6 - 'collecting aliquots of 200 µl' and 'quantify the released ibuprofen',no,narrative,Page 6 - 'the release profile was investigated...',The release profile was investigated collecting aliquots of 200 µl from the dialysis bag at fixed time points...,table_text,Page 3 - 'the drug loading efficiencies at three different drug/polymer ratios (D/P) were evaluated at physiological condition',"...showing the pivotal role of the functional groups, i.e. the hydrophobic tfm group and the guanidino moiety, in stimulating drug encapsulation.",no,no,
10.1007/s11356-025-36536-8,Emerging contaminants: assessing the release of pharmaceuticals via managed aquifer recharge.,GenAI\papers\pdf\10.1007_s11356-025-36536-8__a200c247b9.pdf,text,yes,primary_experiment,yes,yes,no,PAGE 2; Description of experimental setup for column transport,unknown,both,both,Porous media (both unsaturated and saturated),yes,yes,TABLE 3; Details of recovery rates and transport parameters for pharmaceuticals including ibuprofen,no,table_text,TABLE 3,Mass recovery (%) determined by fitting the BTC of nitrate tracer for the saturated column and chloride tracer for the unsaturated column,table_text,TABLE 1,Physical and chemical properties of trace compounds including ibuprofen,no,no,
10.1007/s12247-017-9305-x,Transdermal Delivery of Ibuprofen Utilizing a Novel Solvent-Free Pressure-sensitive Adhesive (PSA): TEPI® Technology.,GenAI\papers\pdf\10.1007_s12247-017-9305-x__5da0ee39f0.pdf,text,yes,primary_experiment,yes,yes,no,PAGE 4: Patches were placed into jacketed diffusion cells (A = 1 cm2).,uncertain,IVPT,both,"Strat-M®, human skin",yes,yes,"PAGE 4: Cumulative amounts and flux values represent the mean of six measurements (n = 6), Table 3, Fig. 4 shows cumulative permeation profiles...",no,table_text,PAGE 4: Table 3 shows cumulative permeated amounts...,"""The cumulative permeated amount for Strat-M after 24 h was found to be 109.47 μg cm−2, whereas for human skin was 85.73 μg cm−2 for the same period (Table 3)...""",table_text,PAGE 4: The list of components used for the synthesis of the optimized formulation is in Table 1.,"""Table 1 List of components used for the synthesis of the optimized formulation for the ibuprofen patch Ingredients Function Mass fraction, wt%...""",no,no,
10.1007/s13346-022-01182-x,Soluplus<sup>®</sup> polymeric nanomicelles improve solubility of BCS-class II drugs.,GenAI\papers\pdf\10.1007_s13346-022-01182-x__b21c07f7ac.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,uncertain,,yes,yes,Results section,no,narrative,Results section,"The cumulative release of ibuprofen from the micelles was significant, with values reported at each time point.",table_text,Table 5,Table 5 presents the size analysis metrics of drug-loaded nanomicelles including ibuprofen.,no,no,"Evidence of endpoint metrics available; however, diffusion cell details are not mentioned."
10.1016/j.bioactmat.2021.01.003,Dual stimuli-responsive polyurethane-based hydrogels as smart drug delivery carriers for the advanced treatment of chronic skin wounds.,GenAI\papers\pdf\10.1016_j.bioactmat.2021.01.003__c66630ee68.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,IVPT,skin,hydrogel,yes,yes,section 2.10,no,narrative,section 2.10,"""Ibuprofen (IBU - Sigma Aldrich, Italy), selected as anti-inflammatory and analgesic model drug... released IBU quantification was carried out using a High Performance Liquid Chromatography (HPLC)...""",unknown,unknown,unknown,no,yes,Study focuses on hydrogel-based delivery of Ibuprofen without explicit mention of a diffusion cell.
10.1016/j.bpj.2009.10.046,Partitioning of nonsteroidal antiinflammatory drugs in lipid membranes: a molecular dynamics simulation study.,GenAI\papers\pdf\10.1016_j.bpj.2009.10.046__ff35a3c449.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,Dipalmitoylphosphatidylcholine (DPPC),no,no,,no,narrative,Results section,...the excess free energy for both the neutral and charged forms of aspirin and ibuprofen...,unknown,,,no,uncertain,
10.1016/j.bpj.2022.10.014,Polystyrene-modified carbon nanotubes: Promising carriers in targeted drug delivery.,GenAI\papers\pdf\10.1016_j.bpj.2022.10.014__41160d2d34.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,Table 1,no,table_text,Table 1,Area per lipid (nm2) and bilayer thickness (nm) values of POPC and with pristine/functionalized CNT models...,table_text,Table 2,Radius of gyration (ROG) and carbon end-to-end (EtE) distances of PS functional groups attached to CNTs...,no,no,
10.1016/j.bpj.2023.02.021,Path sampling with memory reduction and replica exchange to reach long permeation timescales.,GenAI\papers\pdf\10.1016_j.bpj.2023.02.021__bd816ab8eb.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,synthetic_membrane,,yes,yes,"Methodology section, specifically on the permeability derivation from RETIS",no,narrative,"Page 4, paragraph discussing ibuprofen's permeation pathway.","The polar group creates metastable states in ibuprofen’s permeation pathway, which can cause the trajectories to be trapped, making it an excellent application of memory reduction to keep the trajectory lengths short.",unknown,,,no,yes,
10.1016/j.cbpa.2009.12.012,Metal-organic frameworks as potential drug carriers.,GenAI\papers\pdf\10.1016_j.cbpa.2009.12.012__1290ece0a3.pdf,text,no,review,yes,no,no,,,uncertain,uncertain,,yes,yes,PAGE 2,no,narrative,PAGE 2,"Both materials showed high Ibuprofen loading, with 0.347 g Ibuprofen/g MOF for MIL-100 and 1.376 g Ibuprofen/g MOF for MIL-101.",unknown,,,no,no,
10.1016/j.colsurfa.2022.129611,Iron-containing metal-organic framework thin film as a drug delivery system.,GenAI\papers\pdf\10.1016_j.colsurfa.2022.129611__82ceb7e0e7.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,uncertain,,yes,yes,PAGE 8,no,table_text,PAGE 8,"The encapsulation of 8.7 wt % of ibuprofen by MIL-88B is noted, leading to quantifiable change values obtained through QCM analysis.",unknown,,,no,no,
10.1016/j.ejpb.2020.05.013,Design and development of a novel fused filament fabrication (FFF) 3D printed diffusion cell with UV imaging capabilities to characterise permeation in pharmaceutical formulations.,GenAI\papers\pdf\10.1016_j.ejpb.2020.05.013__b451e1b601.pdf,figure,no,primary_experiment,yes,yes,yes,Page 7,Page 3,IVPT,skin,silicone membrane,yes,yes,Page 17,no,figure,Page 17,Figure 11. (a) Average IBU amount in µg/mL permeated vs time.,narrative,Page 5,A 5 % w/w ibuprofen gel formulation was used as the model topical formulation.,no,no,The study demonstrates the use of a newly designed diffusion cell for the IVPT of ibuprofen via a novel method.
10.1016/j.fluid.2020.112842,"Diffusivity of <i>α</i>-, <i>β</i>-, <i>γ</i>-cyclodextrin and the inclusion complex of <i>β</i>-cyclodextrin: Ibuprofen in aqueous solutions; A molecular dynamics simulation study.",GenAI\papers\pdf\10.1016_j.fluid.2020.112842__da00bc55b2.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,uncertain,uncertain,unknown,yes,yes,Page 5,no,narrative,Page 5,self-diffusion coeﬃcients reported in this work are calculated as the average of four independent simulations starting from different initial conﬁgurations.,unknown,unknown,unknown,no,yes,No specific mention of a diffusion cell or Franz cells; focus on molecular dynamics simulation of ibuprofen and β-cyclodextrin.
10.1016/j.heliyon.2019.e02127,Permeability of frog skin to chemicals: effect of penetration enhancers.,GenAI\papers\pdf\10.1016_j.heliyon.2019.e02127__2845bde3ad.pdf,figure,no,primary_experiment,yes,yes,yes,Sections 2.3 and 2.3.1: Diffusion cell experiments,Section 2.3: Diffusion cell experiments,IVPT,skin,Frog skin,yes,yes,Figure 1 and Table 1,no,figure,Section 3.2.1.3: Cumulative absorption versus time curves...,the cumulative absorption versus time curves for ibuprofen,table_text,Table 1,Table 1 presents the solubility data for each chemical in each of the penetration enhancer solutions.,no,no,
10.1016/j.ijpharm.2016.03.043,"A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane.",GenAI\papers\pdf\10.1016_j.ijpharm.2016.03.043__7008480bdc.pdf,figure,no,primary_experiment,yes,yes,yes,PAGE 5,PAGE 5,IVPT,both,"Human skin, Porcine skin, Silicone membrane, PAMPA",yes,yes,PAGE 8,no,figure,PAGE 8,Figure 1 shows cumulative amounts of ibuprofen permeated...,table_text,PAGE 12,Table 1: Excipients included in commercial and experimental formulations and proposed functions...,no,no,
10.1016/j.ijpx.2023.100205,Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions.,GenAI\papers\pdf\10.1016_j.ijpx.2023.100205__36b2f722d0.pdf,text,yes,primary_experiment,yes,yes,yes,Section 2.5,Section 2.7.2,both,skin,human epidermis,yes,yes,Section 3.1,no,narrative,Section 3.1,The amounts of permeated ibuprofen were determined by HPLC.,table_text,Table 1,The compositions of IBSLNs and IBNEs (% w/w).,no,no,
10.1016/j.jsps.2017.03.004,Vapour-phase method in the synthesis of polymer-ibuprofen sodium-silica gel composites.,GenAI\papers\pdf\10.1016_j.jsps.2017.03.004__e3d1f0291a.pdf,text,yes,primary_experiment,yes,yes,no,Section 2.2 - Release of ibuprofen salt,unknown,IVPT,uncertain,Not explicitly stated,yes,yes,Section 3.2 - Results and discussion,no,narrative,The values of parameters characterizing the porosity... predictably correlate with the content of silica gel.,"The drug contents in ternary composites, taking into account the mass of the total carrier system, were estimated to be 39 mg/g for HP-DA...",supplement,This describes the methodology and conditions used during the preparation.,Poly(TRIM) was prepared only with trimethylolpropane trimethacrylate monomer... used as matrices for the preparation of the solid dispersion of ibuprofen sodium.,no,no,"The endpoint data is discussed in terms of release characteristics, framed within the methodology section, supporting the overall outcomes in drug release."
10.1016/j.mtcomm.2022.103205,Physicomechanical properties and in vitro release behaviors of electrospun ibuprofen-loaded blend PEO/EC fibers.,GenAI\papers\pdf\10.1016_j.mtcomm.2022.103205__6696b83bce.pdf,figure,no,primary_experiment,yes,no,no,,,IVRT,both,PEO/EC fibers,yes,yes,PAGE 12,no,figure,Fig. 8 shows the in vitro release curves of IBP from the PEO/EC fibers at various compositions...,"...the cumulative releases of IBP continued to increase to reach a plateau for all fiber formulations containing PEO, suggesting the role of PEO matrix dissolution in the release media that promoted the drug release rates.",narrative,main text,Results suggested that average fiber diameters and average fiber yields approached to a maximum at 50PEO/50EC fiber composition.,no,no,
10.1016/j.neuroscience.2012.08.058,Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat.,GenAI\papers\pdf\10.1016_j.neuroscience.2012.08.058__639064b653.pdf,text,no,primary_experiment,yes,no,no,not applicable,not applicable,uncertain,uncertain,not specified,yes,yes,Results section,no,narrative,"Results section, paragraph describing gene expression data",CD45 gene expression showed a significant 17 fold increase at 7 days post-injury compared to uninjured sham.,narrative,"Methods section, paragraph detailing ibuprofen dosage and administration schedule","At 30 minutes post-FPI, uninjured and brain-injured animals were treated with an initial dose of vehicle (saline) or ibuprofen (20 mg/kg, i.p.) and then daily for 7 days.",no,yes,The study predominantly discusses the effect of ibuprofen in the context of microglial activation post-TBI but does not explicitly use a diffusion cell setup or describe a Franz cell experiment.
10.1016/s0006-3495(03)74603-7,"Lateral diffusion rates of lipid, water, and a hydrophobic drug in a multilamellar liposome.",GenAI\papers\pdf\10.1016_s0006-3495_03_74603-7__c18c29e9ba.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,both,multilamellar liposomes,yes,yes,RESULTS AND DISCUSSION,no,narrative,Discussion on diffusion constant measurement,"The diffusion constant of ibuprofen is (2.1 6 0.1) 3 10^-11 m2/s at 309 K, indicating that numeric data is assessed directly in the results text.",narrative,MATERIALS AND METHODS,"POPC and (S)-(1)-4-isobutyl-a-methylphenylacetic acid ... were co-dissolved in methanol, dried to a thin film under a stream of dry N2...",no,yes,
10.1021/acs.langmuir.2c02497,pH-Responsive Metal-Organic Framework Thin Film for Drug Delivery.,GenAI\papers\pdf\10.1021_acs.langmuir.2c02497__57371a22bd.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,uncertain,uncertain,unknown,yes,yes,Results section,no,narrative,"page 1, Results section",the amount of drug released in acidic environments had been significantly higher compared to that in a neutral system within 55 h of testing time.,narrative,"page 1, Experimental section",A fully functionalized gold sample loaded with ibuprofen was immersed in 60 mL of PBS with 0.5% Tween 20 at room temperature across varying lengths of time.,no,no,The study does not report use of a diffusion cell and lacks IVPT/IVRT terminology.
10.1021/acs.molpharmaceut.0c00515,Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.,GenAI\papers\pdf\10.1021_acs.molpharmaceut.0c00515__ab30082c93.pdf,text,yes,primary_experiment,yes,yes,uncertain,Section 2.2.5 - In Vitro Release,unknown,IVPT,both,PCL-based coatings on implants,yes,yes,Section 3.2 - PCL Film Characterization,no,narrative,Section 3.2 - PCL Film Characterization,Total drug release at each time point was calculated...,table_text,Table 1,Composition of Polymeric Films Prepared by Solution Casting,no,no,
10.1021/acs.molpharmaceut.1c00988,Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches.,GenAI\papers\pdf\10.1021_acs.molpharmaceut.1c00988__320ca28dae.pdf,text,yes,primary_experiment,yes,yes,yes,"Page 4, Section 2.10","Page 3, Figure 3",IVPT,skin,full-thickness neonatal porcine skin,yes,yes,"Page 5, Results Section 3.1",no,narrative,"Page 5, Results Section 3.1","""The incorporation of surfactant enhanced the amount of ibuprofen sodium delivered from 60.61% up to ≈75%""",table_text,Page 3,"""Table 1 outlines the formulation for Dissolving MAP Preparation""",no,no,Study focuses on surfactant impacts on ibuprofen sodium-loaded dissolving MAPs.
10.1021/acsami.4c00383,Coated Cotton Fabrics with Antibacterial and Anti-Inflammatory Silica Nanoparticles for Improving Wound Healing.,GenAI\papers\pdf\10.1021_acsami.4c00383__86c11b19c2.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,Table 2,no,table_text,Table 2,release (%) of ibuprofen and norfloxacin from SiO2@Norflox-Ibu (TEOS/2c 40:1) after treatment with proteases over 24 and 48 hours are presented.,table_text,Table 1,Characterization Data of Functionalized Silica Nanoparticles including drug loading and particle size.,yes,no,
10.1021/acsami.4c16675,Solution Blow Spun Mats with Beaded-Fiber Morphologies as a Drug Delivery System with Potential Use for Skin Wound Dressing.,GenAI\papers\pdf\10.1021_acsami.4c16675__86eb1f4451.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,skin,PCL/PEG mats,yes,yes,"Page 4, In Vitro Ibuprofen Release Studies section",no,narrative,"Page 4, In Vitro Ibuprofen Release Studies section","""At time intervals of 0.5, 1, 2, 3, 4, 5, 24, and 48 h, 2 mL of the solution was withdrawn...""",table_text,"Page 2, Table 1","""Table 1. Samples and the Respective Composition of the Solutions Used To Spin...""",no,no,
10.1021/acsomega.7b01800,Drug-Loaded Supramolecular Gels Prepared in a Microfluidic Platform: Distinctive Rheology and Delivery through Controlled Far-from-Equilibrium Mixing.,GenAI\papers\pdf\10.1021_acsomega.7b01800__9d283ba697.pdf,text,yes,primary_experiment,yes,yes,no,Microfluidic chips section,N/A,IVPT,both,"Gel formed with ibuprofen sodium salt, Gel formation using microfluidic mixing",yes,yes,"Results section, Table 2",no,table_text,Table 2 shows microfluidic mixing gelation experiments and outcomes.,"Table 2 details the flow rates, gel formation status, and gelation times for various conditions.",table_text,Table 1 presents experimental conditions for bulk mixing gelation.,Table 1 includes gelator/ibuprofen ratios and gel formation outcomes.,no,no,
10.1021/acsomega.8b00185,Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration.,GenAI\papers\pdf\10.1021_acsomega.8b00185__4bbfba07e6.pdf,text,yes,primary_experiment,yes,yes,no,Section 2.2,uncertain,both,uncertain,not specified,yes,yes,Figure 3 and Table 1,no,table_text,Table 1,Table 1 shows textural properties of MOFs before and after drug adsorption process.,table_text,Table 1,Table 1 includes total drug loading (wt % and mol·mol−1) and estimated occupancy volume of a single drug molecule.,no,no,
10.1021/acsomega.9b01139,Synthesis and Functionalization of Porous Zr-Diaminostilbenedicarboxylate Metal-Organic Framework for Storage and Stable Delivery of Ibuprofen.,GenAI\papers\pdf\10.1021_acsomega.9b01139__d21daeb09a.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,uncertain,,yes,yes,Results,no,table_text,Table 3,Table 3 provides quantitative results for loading capacities and adsorption parameters.,table_text,Table 2,Table 2 summarizes the concentrations of −COOH groups determined by acid−base titration and yields of modification of Zr-DASDCA.,no,no,This study focuses on the delivery of ibuprofen using modified Zr-MOFs.
10.1021/acsomega.9b03696,Tuning Crystal Structures of Iron-Based Metal-Organic Frameworks for Drug Delivery Applications.,GenAI\papers\pdf\10.1021_acsomega.9b03696__93213756c4.pdf,figure,no,primary_experiment,yes,no,no,,,IVPT,uncertain,,yes,yes,Figure 5,no,figure,Figure 5 displays the cumulative ibuprofen released from treated MIL-53 and MIL-88B as a function of an immersing time.,"Figure 5 shows the cumulative drug release percentages for ibuprofen over time, indicating elution at multiple time points.",unknown,,,no,no,
10.1021/mp500264e,Crystallographic textures and morphologies of solution cast Ibuprofen composite films at solid surfaces.,GenAI\papers\pdf\10.1021_mp500264e__0344a1a460.pdf,figure,no,primary_experiment,yes,no,no,,,IVPT,uncertain,,yes,yes,PAGE 6,no,figure,"Figure 6 shows the ibuprofen dissolution from various matrix materials as a function of time, incorporating IVPT metrics.",The released Ibu amount is very similar to the MC sample after and is about 30 mg.,narrative,Text in the Results section describes the formulation details and dissolution results.,Dissolution experiments demonstrated the impact of the matrix material on the API release.,no,no,
10.1038/s41467-017-00763-6,Printing of small molecular medicines from the vapor phase.,GenAI\papers\pdf\10.1038_s41467-017-00763-6__d818b9d77d.pdf,text,yes,primary_experiment,yes,yes,no,"Page 1, paragraph 1 discusses various delivery vehicles including transdermal systems and microneedles.",uncertain,IVPT,both,"Glasses, Tegaderm, and microneedles",yes,yes,"Page 7, last paragraph discusses dissolution rates and comparisons over time.",no,narrative,"Page 7, paragraph where dissolution rates are discussed.","""...the initial dissolution rates in films is very rapid and constant up to ~80% of the film being dissolved.""",table_text,"Table 1 on Page 3, summarizes OVJP processing conditions.","""Table 1 summarizes OVJP processing conditions for materials used in the study.""",no,no,The study demonstrates significant enhancement in dissolution rate of ibuprofen through vapor jet printing.
10.1038/s41598-017-03195-w,Sustained release from a metal - Analgesics entrapped within biocidal silver.,GenAI\papers\pdf\10.1038_s41598-017-03195-w__88e14f492f.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,uncertain,uncertain,unknown,yes,yes,Table 2,no,table_text,Table 2,Table 2 collects the parameters of the release profiles of the entrapped NSAIDs.,table_text,Table 1,Table 1 shows some details of the sustained release measurements.,no,no,
10.1038/s41598-020-74885-1,Fabrication of tri-layered electrospun polycaprolactone mats with improved sustained drug release profile.,GenAI\papers\pdf\10.1038_s41598-020-74885-1__7b671a04bd.pdf,figure,no,primary_experiment,yes,no,no,,,IVPT,uncertain,,yes,yes,PAGE 7,no,figure,Figure 7,Cumulative (%) IBU release for 62 days. Cumulative (%) release comparison for all groups.,table_text,Table 1,Composition of sandwich and non-sandwich mats.,no,no,
10.1038/s41598-022-05912-6,Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery.,GenAI\papers\pdf\10.1038_s41598-022-05912-6__a14138d102.pdf,text,yes,primary_experiment,yes,yes,no,Page 5 (in vitro drug release of lidocaine and ibuprofen microneedles),uncertain,IVPT,skin,porcine skin,yes,yes,Page 4,no,table_text,Page 4,The release profile shows that each patch (containing 100 microneedles) roughly releases 1 mg of drug in DPBS solution after 2 h by dissolution-diffusion mechanism.,supplement,Page 4,We performed a detailed release study in DPBS medium for both Ibuprofen and Lidocaine microneedle patches.,no,no,
10.1038/s41598-024-57883-5,Compatibilizing of cotton fabric with hydrophobic drug cover layer for anti-inflammatory performance with the implementation of ibuprofen.,GenAI\papers\pdf\10.1038_s41598-024-57883-5__112cba5049.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,cotton fabric,yes,yes,Results section,no,narrative,Results section,"""The theoretical amount of loaded ibuprofen results from the proportion of the drug in correlation to the amount of cotton fabric used and is 1 mg/cm2.""",unknown,,,no,yes,
10.1038/s41598-024-71609-7,"Ultrasonic synthesis, characterization, DFT and molecular docking of a biocompatible Zn-based MOF as a potential antimicrobial, anti-inflammatory and antitumor agent.",GenAI\papers\pdf\10.1038_s41598-024-71609-7__22f203f8b1.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,uncertain,uncertain,unknown,yes,no,narrative,no,narrative,PAGE 1,The anti-inflammatory treatment of Zn-MOF achieved 75.0% efficiency relative to the standard Ibuprofen drug.,unknown,unknown,unknown,no,no,
10.1038/s41598-024-82564-8,Design and optimization of hollow microneedle spacing for three materials using finite element methods.,GenAI\papers\pdf\10.1038_s41598-024-82564-8__1f27a4aa14.pdf,figure,no,primary_experiment,yes,yes,no,PAGE 11,unknown,IVPT,skin,skin model,yes,no,PAGE 12,no,figure,PAGE 11,The velocity variations were shown in Fig. 19. We found that the initial velocity of fluid increased with increasing pressure at the inlet.,narrative,PAGE 12,The fluid in the lumen is water and lidocaine ibuprofen ([Lid][Ibp]).,no,no,"Study focuses on microneedle design, including ibuprofen properties and flow dynamics."
10.1038/s41598-025-89540-w,Multi spectroscopic investigation of maisine-based microemulsions as convenient carriers for co-delivery of anticancer and anti-inflammatory drugs.,GenAI\papers\pdf\10.1038_s41598-025-89540-w__8b4b299fb0.pdf,text,yes,primary_experiment,yes,yes,uncertain,methods section,unknown,IVRT,both,"microemulsions, liposomes",yes,yes,Results section,no,table_text,Table 2,Table 2 lists the final composition of the nine drug(s)-loaded MEs and the free drug MEs used in this study.,table_text,Table 1,Table 1 shows the different formulations and compositions used in the study.,no,no,"Study investigates ibuprofen in microemulsions and liposomes, assessing release behaviors."
10.1038/sj.bjp.0702427,"In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin.",GenAI\papers\pdf\10.1038_sj.bjp.0702427__4215057e1b.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,uncertain,uncertain,unknown,yes,yes,Results Section,no,narrative,PAGE 5 (Results Section),Capsaicin-evoked PGE2 release was signi®cantly decreased by S(+) ibuprofen in a dose-dependent manner.,unknown,PAGE 2 (Methods Section),S(+) ibuprofen was dissolved to 5 mg ml71 in 100% w v71 dimethyl sulphoxide.,no,yes,Insufficient information on diffusion cells or explicit Franz cells.
10.1038/srep05251,Expression of human solute carrier family transporters in skin: possible contributor to drug-induced skin disorders.,GenAI\papers\pdf\10.1038_srep05251__d6149d5091.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,PAGE 5,no,narrative,PAGE 5,"...cell viability dropped to 80% and 60% when treated with 0.1 mM and 1.0 mM ibuprofen acyl-glucuronide, respectively...",unknown,,,no,uncertain,The study did not explicitly confirm the use of diffusion cells or Franz cells for ibuprofen but does study effects related to ibuprofen.
10.1038/srep39778,High-Quality Metal-Organic Framework ZIF-8 Membrane Supported on Electrodeposited ZnO/2-methylimidazole Nanocomposite: Efficient Adsorbent for the Enrichment of Acidic Drugs.,GenAI\papers\pdf\10.1038_srep39778__ae09f550c3.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,synthetic_membrane,ZIF-8 membrane,yes,yes,Table 1,no,table_text,Table 1,"Table 1 summarizes the Langmuir model parameters for ibuprofen adsorption, showing qmax (mg/g) and KL (L/μg) values.",unknown,,,no,yes,The study discusses adsorption properties of ibuprofen but does not provide a dedicated formulation table.
10.1039/c9ra02868d,Supramolecular gels from sugar-linked triazole amphiphiles for drug entrapment and release for topical application.,GenAI\papers\pdf\10.1039_c9ra02868d__d723b2a34a.pdf,text,yes,primary_experiment,yes,yes,no,Experiment section,N/A,IVPT,skin,"n-hexane, n-heptane, methanol",yes,yes,Results section,no,table_text,Table 1,Table 1 shows gelation ability of tetritol-based triazole-linked lipid derivatives.,narrative,Experiment section,"The gelators, owing to the amphiphilic nature... were utilized to entrap ibuprofen and 5-fluorouracil.",no,no,
10.1039/d0ra00100g,Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters.,GenAI\papers\pdf\10.1039_d0ra00100g__a0517498c9.pdf,text,yes,primary_experiment,yes,yes,yes,PAGE 6,PAGE 5,IVPT,skin,porcine skin,yes,yes,PAGE 6,no,table_text,Table 2,The solubility was established and summarised in Table 2.,table_text,Table 1,The properties of ibuprofen and its L-valine ester derivatives are summarized in Table 1.,no,no,The study explores formulations of ibuprofen derivatives for enhanced skin permeation using Franz diffusion cells.
10.1039/d0ra01444c,"Assembly of lignin-based colloidal particles: effects of cationic surfactants, molecular weight, and solvent on morphology.",GenAI\papers\pdf\10.1039_d0ra01444c__0bc0fa001a.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,both,"simulated gastric fluid (SGF), simulated intestinal fluid (SIF)",yes,yes,section 3.4 Controlled release behaviors and in vitro release studies,no,narrative,section 3.4,"At pH 1.2, the drug release rate was slow, with only 6.35% of IBU released after 6 h and 14.81% after 48 h.",table_text,Table 1,The IBU loading rate and encapsulation efficiency values of LS/CTAB are shown in Table 1.,no,no,
10.1039/d0ra06567f,The effect of alcohols as vehicles on the percutaneous absorption and skin retention of ibuprofen modified with l-valine alkyl esters.,GenAI\papers\pdf\10.1039_d0ra06567f__15dc420ec6.pdf,text,yes,primary_experiment,yes,yes,yes,"PAGE 1, first paragraph","PAGE 1, first paragraph",IVPT,skin,porcine skin,yes,yes,"PAGE 4, second paragraph",no,narrative,"PAGE 4, second paragraph",The cumulative mass of compound in skin after 24 hours of permeation (n = 3) – acceptor phase with pH 5.4 ...,supplement,"PAGE 1, supplementary information",see Supporting Information Table S6...,yes,no,Study uses both unmodified ibuprofen and its derivatives for IVPT.
10.1039/d1ra07761a,Comparison of drug release behavior of bacterial cellulose loaded with ibuprofen and propranolol hydrochloride.,GenAI\papers\pdf\10.1039_d1ra07761a__97a74e7554.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,synthetic_membrane,bacterial cellulose (BC),yes,yes,"Results section, specifically under drug release study",no,table_text,Table 2,Table 2 shows the swelling ratios of air-dried and freeze-dried membranes after different immersion times.,table_text,Table 1,"Table 1 lists name, composition, and drying method of each prepared BC loaded with the drug and the control BC.",no,no,
10.1039/d2ra05804a,New amino acid propyl ester ibuprofenates from synthesis to use in drug delivery systems.,GenAI\papers\pdf\10.1039_d2ra05804a__cf2f535409.pdf,text,yes,primary_experiment,yes,yes,no,narrative,unknown,IVPT,skin,pig skin,yes,yes,Table 4,no,table_text,Table 4,Table 4 lists cumulative permeation values and other permeability parameters for ibuprofen derivatives.,narrative,Results and discussion,...the formation of structural modifications of ibuprofen in the form of charged compounds with lower lipophilicity influences better permeability than the more lipophilic ibuprofen.,no,no,Study focuses on new ibuprofen derivatives and their permeability through skin.
10.1039/d3na00102d,Ibuprofen-loaded electrospun poly(ethylene-<i>co</i>-vinyl alcohol) nanofibers for wound dressing applications.,GenAI\papers\pdf\10.1039_d3na00102d__3fe1ba65d9.pdf,text,yes,primary_experiment,yes,yes,no,"Page 1, Methods section",unknown,IVPT,skin,poly(ethylene-co-vinyl alcohol) nanofibers,yes,yes,"Page 6, Results",no,narrative,"Page 6, Results section",The relative release of IBU was evaluated at 25 °C and 37.5 °C in phosphate-buffered saline (PBS) solution...,table_text,"Page 5, Table 1",Parameters used for the electrospinning of EVOH nanoﬁbers...,no,no,
10.1039/d5ra05217c,Piezoelectric electrospun scaffold incorporating ibuprofen loaded ultrasound-responsive mesoporous silica nanoparticles for tissue regeneration.,GenAI\papers\pdf\10.1039_d5ra05217c__c723345e54.pdf,text,yes,primary_experiment,yes,yes,uncertain,"In the description of drug release tests, indicating the use of a controlled environment for diffusion studies.",uncertain,IVPT,skin,piezoelectric electrospun scaffold,yes,yes,Section 2.4 - Manufacturing and characterisation of PVDF scaffold.,no,table_text,Section 2.4,"The release tests were conducted in triplicate, indicating numerical cumulative values of ibuprofen release over time.",unknown,Section 2.4,Details on formulation with IBU@MSN-SA-Ca nanoparticles.,no,no,The study extensively discusses the synthesis of ibuprofen-loaded nanoparticles and their release mechanism.
10.1063/1.4946867,Attenuated total reflection-Fourier transform infrared spectroscopic imaging of pharmaceuticals in microfluidic devices.,GenAI\papers\pdf\10.1063_1.4946867__507064c9a2.pdf,figure,no,primary_experiment,yes,yes,no,Page 4 - descriptions of microfluidic devices for studying drug release,uncertain,IVPT,both,micro-formulations; pH media,yes,yes,Page 7 - description of drug release at 20 min,no,figure,Fig. 3,Fig. 3 demonstrates that it is possible to study four different channels simultaneously...complete release of ibuprofen in the pH 7 aqueous medium is observed after 20 min.,narrative,Page 6,"Micro-formulations containing a model drug, ibuprofen, and excipient, PEG... were prepared and dispensed using a microdrop system...",no,no,
10.1080/10837450.2018.1509347,An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin.,GenAI\papers\pdf\10.1080_10837450.2018.1509347__a7e143a067.pdf,text,yes,primary_experiment,yes,yes,yes,PAGE 4,PAGE 7,IVPT,skin,full-thickness human skin,yes,yes,PAGE 7,no,table_text,PAGE 6,Table 2 shows the cumulative permeation of ibuprofen at various timepoints...,table_text,PAGE 6,Table 2 details the formulation parameters used for ibuprofen across the diffusion cells.,no,no,
10.1097/opx.0000000000000849,Controlled Release of Multiple Therapeutics from Silicone Hydrogel Contact Lenses.,GenAI\papers\pdf\10.1097_opx.0000000000000849__43748dc834.pdf,figure,no,primary_experiment,yes,yes,no,"Page 5, 6",uncertain,IVPT,both,silicone hydrogel lenses,yes,yes,Page 8,no,figure,"Page 8, Results section","""The cocktail of molecules for the combination release devices were 120 kDa HPMC, trehalose, prednisolone, and ibuprofen (Figure 8).""",narrative,"Page 1, Methods section","""Four template molecules were selected for incorporation and release from the hydrogel lenses. The template molecules selected were 120 kilodalton (kDa) hydroxylpropyl methylcellulose (HPMC), trehalose, ibuprofen, and prednisolone.""",no,yes,Study highlights the use of controlled release in hydrogels for multiple therapeutics including ibuprofen.
10.1097/pr9.0000000000001073,Systematic review of topical interventions for the management of pain in chronic wounds.,GenAI\papers\pdf\10.1097_pr9.0000000000001073__c54af60247.pdf,text,no,review,yes,no,no,,,uncertain,uncertain,,yes,yes,Table 1,no,table_text,Table 1 provides summaries of results related to ibuprofen interventions.,"""Table 1 summarizes results including pain intensity scores across various studies comparing ibuprofen with controls.""",unknown,,,no,no,
10.1098/rsfs.2019.0132,&lt;i&gt;In vitro&lt;/i&gt; and computational modelling of drug delivery across the outer blood-retinal barrier.,GenAI\papers\pdf\10.1098_rsfs.2019.0132__2fa2660da2.pdf,text,yes,primary_experiment,yes,yes,no,"Page 1, Figure 1b",uncertain,IVPT,both,outer blood-retinal barrier,yes,yes,"Page 4, Section 2.2.3",no,narrative,"Page 4, Section 2.2.3","At defined time points, 100 µl samples were taken from the PBS, transferred to UV transparent cuvettes...",unknown,uncertain,uncertain,no,no,"It describes study conditions for ibuprofen release, but no detailed tables or specific formulations are provided in the main text."
10.1111/j.1476-5381.1991.tb09844.x,Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1.,GenAI\papers\pdf\10.1111_j.1476-5381.1991.tb09844.x__6343051e7e.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,Table 2,no,table_text,Table 2,"Effect of pretreatment with the cyclo-oxygenase inhibitor ibuprofen (10mgkg-1) on serum thromboxane B2 (TXB2) and markers of renal damage and urinary prostaglandin excretion after anti-glomerular-basement-membrane antibodies and interleukin-i1, (a-GBM/IL-1,,) - Ibuprofen + Ibuprofen Serum TXB2 (ngml- ')",table_text,Table 1,The results of the renal morphology and functional studies are summarised in Table 1. a-GBM alone decreased creatinine clearance by 68% at 24h.,no,no,
10.1155/2015/892671,Formulation of Novel Layered Sodium Carboxymethylcellulose Film Wound Dressings with Ibuprofen for Alleviating Wound Pain.,GenAI\papers\pdf\10.1155_2015_892671__9b42388c10.pdf,text,yes,primary_experiment,yes,yes,yes,"PAGE 4, Section 2.2.6","PAGE 4, Section 2.2.6",IVRT,synthetic_membrane,Franz diffusion cell,yes,yes,"PAGE 5, Results and Discussion",no,narrative,"PAGE 5, Section 3.1","""The ibuprofen concentration in the films was expressed as mg/cm2 of film.""",table_text,"PAGE 3, Table 1","""Table 1: Preparation of layered films.""",no,no,
10.1155/2023/5535344,"Extraction, Characterization, and Evaluation of <i>Lepidium sativum</i> Linn. Mucilage as a Mucoadhesive Polymer.",GenAI\papers\pdf\10.1155_2023_5535344__058ccb5240.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,synthetic_membrane,,yes,yes,PAGE 5,no,table_text,Table 1 shows the compositions of ibuprofen microsphere formulations.,Ingredients (g) Formulations F1 F2 F3 F4 F5 F6 Ibuprofen 5 5 5 5 5 5 LSM 1 3 5 — — — HPMC K100M — — — 1 3 5,table_text,Table 1 provides details of the formulations of ibuprofen microspheres.,Ingredients (g) Formulations F1 F2 F3 F4 F5 F6 Ibuprofen 5 5 5 5 5 5 LSM 1 3 5 — — — HPMC K100M — — — 1 3 5,no,no,
10.1186/2050-6511-13-5,Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points.,GenAI\papers\pdf\10.1186_2050-6511-13-5__eabb128fb8.pdf,text,yes,primary_experiment,yes,yes,yes,"PAGE 2, Methods section","PAGE 1, Results section",IVPT,skin,bovine udder skin,yes,yes,"PAGE 4, Table 1",no,table_text,"PAGE 4, Table 1",Table 1 shows cumulative permeation parameters for ibuprofen under varying microneedle pretreatment conditions.,table_text,"PAGE 4, Table 1",Table 1 lists the formulation parameters for ibuprofen and other tested compounds.,no,no,Study effectively demonstrates ibuprofen's diffusion characteristics using Franz-type cells and microneedle enhancements.
10.1186/s12951-020-00718-y,Synthesis and application of magnetic@layered double hydroxide as an anti-inflammatory drugs nanocarrier.,GenAI\papers\pdf\10.1186_s12951-020-00718-y__c400793e91.pdf,text,yes,primary_experiment,yes,yes,no,Page 3,unknown,IVRT,synthetic_membrane,PBS,yes,yes,Page 9,no,narrative,Page 9,"The release rate of Ibuprofen was 90% within 24 h, 94% in 48 h, and 96% in 72 h.",unknown,unknown,unknown,no,no,IBU release measured over time in IVRT testing.
10.1208/pt020424,Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.,GenAI\papers\pdf\10.1208_pt020424__f519f890d2.pdf,figure,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,Figure 5,no,figure,Figure 5,Figure 5 shows dissolution profiles of ibuprofen from coated beads.,narrative,Conclusion section,The dissolution rate of ibuprofen could be controlled and stabilized by use of the polymeric plasticization technique.,no,no,
10.1208/s12249-009-9228-z,Anhydride prodrug of ibuprofen and acrylic polymers.,GenAI\papers\pdf\10.1208_s12249-009-9228-z__ed60a39704.pdf,figure,no,primary_experiment,yes,yes,no,PAGE 6,unknown,IVPT,synthetic_membrane,Eudragit L-100 and S-100,yes,yes,PAGE 6,no,figure,"PAGE 6, Figure 5 shows in vitro release properties of ibuprofen.",Fig. 5 shows the drug release proﬁles from the conjugate and the microspheres.,table_text,"PAGE 3, Table I summarizes the anhydride parameters including drug loading.",Table I details the anhydride parameters such as yields and drug loading percentages.,no,no,
10.1208/s12249-010-9449-1,In vitro enhancement of lactate esters on the percutaneous penetration of drugs with different lipophilicity.,GenAI\papers\pdf\10.1208_s12249-010-9449-1__20e37a8b8e.pdf,text,yes,primary_experiment,yes,yes,yes,Page 4,Page 4,IVPT,skin,hairless rat skin,yes,yes,Table 3,no,table_text,Table 3,The effect of the lactate esters on percutaneous permeation of IBU through hairless rat skin is summarized in Table III.,table_text,Table I,The physicochemical parameters of these model drugs are presented in Table I.,no,no,Lactate esters were used as penetration enhancers. Numerical results showing cumulative amounts and timepoints for ibuprofen are present.
10.1208/s12249-010-9522-9,Validation of a static Franz diffusion cell system for in vitro permeation studies.,GenAI\papers\pdf\10.1208_s12249-010-9522-9__9004f70379.pdf,text,yes,primary_experiment,yes,yes,yes,PAGE 1,PAGE 1,IVPT,synthetic_membrane,synthetic membranes,yes,yes,PAGE 4,no,table_text,PAGE 4,Table shows plots of cumulative % ibuprofen drug permeation through each synthetic membrane against time.,table_text,PAGE 5,The study involved saturated solutions prepared by adding excess ibuprofen...,no,no,Study validated a Franz cell system for ibuprofen diffusion using synthetic membranes.
10.1208/s12249-013-9953-1,Drug-loaded zein nanofibers prepared using a modified coaxial electrospinning process.,GenAI\papers\pdf\10.1208_s12249-013-9953-1__81485635ae.pdf,figure,no,primary_experiment,yes,no,no,,,IVRT,uncertain,,yes,yes,"PAGE 6, Fig. 7",no,figure,"Page 6, Fig. 7","The IBU release profiles of fibers F1, F2, and F3 are shown in Fig. 7.",narrative,"Page 6, Results and Discussion, second last paragraph",The cumulative amount of IBU released at each time point was reverse calculated from the data obtained against a predetermined calibration curve.,no,no,
10.1208/s12249-013-9995-4,Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study.,GenAI\papers\pdf\10.1208_s12249-013-9995-4__48cbfe0b17.pdf,text,yes,primary_experiment,yes,yes,yes,PAGE 2,PAGE 2,IVPT,skin,porcine skin,yes,yes,PAGE 5,no,table_text,Table III shows the cumulative amount of drug permeated (μg) for different formulations over time.,"Cumulative amount of drug permeated (μg) at different times: 24h (798.9), 48h (1178.9)...",table_text,Table I outlines the compositions of ibuprofen nanosuspension formulations.,"Compositions of Ibuprofen Nanosuspension Formulations: Code, Vit. E TPGS, HPMC K4...",no,no,
10.1208/s12249-015-0474-y,Regulating the Skin Permeation Rate of Escitalopram by Ion-pair Formation with Organic Acids.,GenAI\papers\pdf\10.1208_s12249-015-0474-y__b08f9feea7.pdf,text,yes,primary_experiment,yes,yes,no,PAGE 2 - In Vitro Permeation Experiments,uncertain,IVPT,skin,rabbit abdominal skin,yes,yes,Table III,no,table_text,Table III,"Table III shows the permeation data and physicochemical parameters for ESP with or without various organic acids (mean ± SD, n = 4) including Q8h and J values.",table_text,Table III,Table III summarizes the flux values of ESP ion-pair complexes with various organic acids.,no,no,
10.1208/s12249-018-1095-z,Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology.,GenAI\papers\pdf\10.1208_s12249-018-1095-z__52c47dee3a.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,results section,no,narrative,The results section discusses drug release profiles including lag time.,"In this investigation, formulations with < 20% drug release in 6 h (lag time) were considered to meet the requirements of the optimized chronotherapeutic drug delivery system...",table_text,Formulation compositions and processing parameters are listed in Table II.,"...composition of different formulations, processing parameters, and percent drug released after lag time (6 h) using the 6-mm extruder is listed in Table I.",no,no,
10.1208/s12249-019-1481-1,Effects of Temperature and Humidity on the Skin Permeation of Hydrophilic and Hydrophobic Drugs.,GenAI\papers\pdf\10.1208_s12249-019-1481-1__47e0b4fbb9.pdf,figure,no,primary_experiment,yes,yes,yes,Page 2,Page 2,IVPT,skin,excised porcine ear skin,yes,yes,Page 6,no,figure,Page 6,"Figure 2a, b shows the cumulative amount of IP and ANP that permeated through the skin at different temperatures and humidities, respectively.",table_text,Page 4,Table I shows the composition of the vehicle solution used for saturation of the drugs.,no,no,
10.1208/s12249-019-1584-8,Transcutol® P/Cremophor® EL/Ethyl Oleate-Formulated Microemulsion Loaded into Hyaluronic Acid-Based Hydrogel for Improved Transdermal Delivery and Biosafety of Ibuprofen.,GenAI\papers\pdf\10.1208_s12249-019-1584-8__85f231cdcc.pdf,figure,no,primary_experiment,yes,yes,yes,"Page 4, in vitro Transdermal Test section","Page 4, in vitro Transdermal Test section",IVPT,skin,rat skin,yes,yes,"Page 6, Fig. 3",no,figure,"Page 6, Fig. 3",Fig. 3 shows cumulative permeation profiles of ibuprofen-loaded preparations over 24 hours.,table_text,"Page 4, Table I","Table I lists the composition of the Ibuprofen-Loaded formulations including ME/Gel, Gel, and Cream.",no,no,Study demonstrates the effectiveness of microemulsion-based hydrogel for ibuprofen transdermal delivery.
10.1248/cpb.c21-00033,Use of Silicone Membrane Permeation to Assess Thermodynamic Activities of Ionic Liquids and Their Component Cation and Anion.,GenAI\papers\pdf\10.1248_cpb.c21-00033__567266ad06.pdf,figure,no,primary_experiment,yes,yes,no,Page 3 - Membrane Permeation Experiments: The silicone membrane was cut slightly larger than the effective diffusional area of the horizontal two-chamber diffusion cell.,uncertain,IVPT,synthetic_membrane,silicone membrane,yes,yes,Page 5 - Figure 4: Relationship between Theoretical and Observed Permeation Rates of Lidocaine (a) and Ibuprofen (b)...,no,figure,Page 5 - Figure 4,Figure 4 shows both observed and theoretical values for the permeation rates of ibuprofen through the silicone membrane.,table_text,Page 4 - Table 2,"Table 2 shows the molar fraction in IL, lidocaine, and ibuprofen at and after IL preparation.",no,no,
10.1371/journal.pone.0130253,Synthesis Mechanism and Thermal Optimization of an Economical Mesoporous Material Using Silica: Implications for the Effective Removal or Delivery of Ibuprofen.,GenAI\papers\pdf\10.1371_journal.pone.0130253__a83f2a886f.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,"Results section, p. 9",no,narrative,"Results section, p. 9","The qeq of IBP uptake by MSM–500 was 22.8 mg g–1 at 299 K, but decreased to 18.28 and 7.7 mg g–1 at 309 and 319 K, respectively.",narrative,"Materials and Methods, p. 5","To load IBP, 0.2 g of MSM–500 was added to a hexane solution containing 30 mg mL–1 IBP.",no,no,
10.1371/journal.pone.0156931,Use of a Tissue Engineered Human Skin Model to Investigate the Effects of Wounding and of an Anti-Inflammatory on Melanoma Cell Invasion.,GenAI\papers\pdf\10.1371_journal.pone.0156931__84dcffdf1d.pdf,text,yes,primary_experiment,yes,yes,no,Materials and Methods,n/a,both,skin,Tissue Engineered Human Skin Model,yes,yes,Results,no,table_text,Table 4,Table 4 summarizes the experimental results regarding melanoma cell invasion.,table_text,Table 3,Table 3 provides a summary of the effects of various treatments including ibuprofen on melanoma invasion.,no,no,
10.14440/jbm.2020.319,An <i>ex vivo</i> skin model to probe modulation of local cutaneous arachidonic acid inflammation pathway.,GenAI\papers\pdf\10.14440_jbm.2020.319__1be6b1975c.pdf,text,yes,primary_experiment,yes,yes,yes,"Page 4, where the setup of the Franz diffusion cell is described.","Page 4, where it says the setup allows the determination of xenobiotic transport.",IVPT,skin,porcine skin,yes,yes,"Page 5, where transdermal delivery parameters are discussed.",no,narrative,Page 5,Samples are taken from the receptor phase and analyzed for penetrant to determine transdermal delivery parameters.,unknown,unknown,unknown,no,no,
10.18433/j3160b,A new vesicle-loaded hydrogel system suitable for topical applications: preparation and characterization.,GenAI\papers\pdf\10.18433_j3160b__e18921d9f7.pdf,figure,no,primary_experiment,yes,yes,no,"Section ""Release experiments""",uncertain,IVPT,skin,"not explicitly stated, but refers to skin in context",yes,yes,Figure 3,no,figure,Figure 3,Figure 3 shows release profiles of IBU and CAFF from the LBG/Xanth gel (empty symbols) and from the loaded NSVs-LBG/Xanth systems (full symbols)...,unknown,uncertain,uncertain,no,yes,Study focuses on the release profiles of ibuprofen in a hydrogel system.
10.2147/ijn.s267614,A New Type of MgFe<sub>2</sub>O<sub>4</sub>@CuS-APTES Nanocarrier for Magnetic Targeting and Light-Microwave Dual Controlled Drug Release.,GenAI\papers\pdf\10.2147_ijn.s267614__f112c3096a.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,PAGE 9,no,narrative,PAGE 9,"""After five cycles, the drug-release percentage was 90% and 66% separately, and could be adjusted by the time and cycles times of electromagnetic wave and NIR light irradiation.""",narrative,PAGE 3,"""the characteristic IBU absor­ bance at 220 nm in the supernatant was measured using an UV−vis spectrophotometer.""",no,no,
10.2147/ijn.s34700,Modification of palm kernel oil esters nanoemulsions with hydrocolloid gum for enhanced topical delivery of ibuprofen.,GenAI\papers\pdf\10.2147_ijn.s34700__130ce08dfa.pdf,text,yes,primary_experiment,yes,yes,yes,PAGE 4,PAGE 2,IVPT,skin,rat skin,yes,yes,PAGE 7,no,table_text,"PAGE 7, Table 4","Table 4 shows the permeation parameters of T802 and M1, detailing cumulative amounts over the given time periods.",table_text,"PAGE 2, Table 1 and Table 2",Table 1 presents the formulation components including ibuprofen in the nanoemulsion.,no,no,
10.2147/ijn.s504924,An Injectable Ibuprofen Sustained-Release Composite Hydrogel System Effectively Accelerates Diabetic Wound Healing via Anti-Inflammatory Effects and Angiogenesis.,GenAI\papers\pdf\10.2147_ijn.s504924__606e9f23a6.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,both,,yes,yes,Table 2,no,table_text,Table 2,Table 2 shows cumulative released ibuprofen amounts...,table_text,Table 1,Table 1 summarizes the formulation ratios...,no,no,
10.22037/ijpr.2019.1100769,Facile Synthesis and Characterization of Ibuprofen-mesoporous Hydroxyapatite Nanohybrid as a Sustained Drug Delivery System.,GenAI\papers\pdf\10.22037_ijpr.2019.1100769__801c3bb021.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,PAGE 8,no,narrative,PAGE 8,"The amount of IBU incorporated into the pores of MHANPs increased with increasing loading time, until incorporation equilibrium was established within 24 h.",unknown,,,no,no,
10.22037/ijpr.2020.112887.14003,Development and Characterization of Niosomal Gel System using <i>Lallementia royaleana Benth.</i> mucilage for the treatment of Rheumatoid Arthritis.,GenAI\papers\pdf\10.22037_ijpr.2020.112887.14003__d40fecc1d7.pdf,text,yes,primary_experiment,yes,yes,yes,Page 7,Page 7,IVPT,skin,excised rat skin,yes,yes,Page 12,no,table_text,Table 4,"Results for Amount permeated, Drug flux, and Log permeability coefficient of the Ibuprofen loaded Niosomal gel formulations.",table_text,Table 1,"Formulations (Surfactant: Cholesterol Ratio), Entrapment efficiencies (EE%), Mean Vesicle Size (MVS), Cumulative Percent Release (CPR) of all Ibuprofen loaded Niosome Formulations.",no,no,
10.3389/fbioe.2020.00708,Thermosensitive Micellar Hydrogels as Vehicles to Deliver Drugs With Different Wettability.,GenAI\papers\pdf\10.3389_fbioe.2020.00708__d9ee953557.pdf,text,no,primary_experiment,yes,no,no,N/A,N/A,uncertain,skin,thermosensitive micellar hydrogels,yes,yes,page 5,no,narrative,"page 5, second paragraph, first sentence","""The relationship between drug wettability and their release mechanism and timing from micellar hydrogels was studied through drug release tests conducted up to 14 days at 37◦C.""",narrative,"page 3, paragraph two, second sentence","""In addition, both drug-loaded and not-loaded hydrogels were qualitatively and quantitatively characterised through tube inverting and gelation time tests and rheological analyses.""",no,no,
10.3389/fchem.2024.1369542,"Investigation of the synthesis, gelation potential, and drug-loading capacities of two novel amides.",GenAI\papers\pdf\10.3389_fchem.2024.1369542__fb74094c52.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,Table 5,no,table_text,Table 5,Ibuprofen- and naproxen-loading capacity of gels with fatty acid esters of organogelator 1.,table_text,Table 1,"MGC of organogelators, mg/mL-1.",no,no,
10.3389/fphar.2024.1355283,Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage.,GenAI\papers\pdf\10.3389_fphar.2024.1355283__d3e3b20e27.pdf,text,no,primary_experiment,yes,yes,no,PAGE 1,unknown,IVPT,both,tympanic membrane and round window membrane,yes,uncertain,PAGE 1,no,narrative,PAGE 1,"As expected, our data indicate that the conjugate has limited tympanic membrane model permeability; however, it readily permeated the round window membrane model and to a greater extent than the unconjugated drug.",unknown,unknown,unknown,no,yes,"The data presented indicates the use of ibuprofen-HA conjugates for assessing permeability, but specific numeric cumulative values or endpoint timepoints are not detailed in the available text."
10.3390/antibiotics10070805,In Vitro Microbiological and Drug Release of Silver/Ibuprofen Loaded Wound Dressing Designed for the Treatment of Chronically Infected Painful Wounds.,GenAI\papers\pdf\10.3390_antibiotics10070805__b6bca2ab5d.pdf,text,yes,primary_experiment,yes,yes,yes,Section 3.3.3,Paragraph discussing previous works,IVPT,uncertain,uncertain,yes,yes,Section 3.3.3,no,narrative,Section 3.3.3,the totality of the IBU-L loaded was released in 1 h.,narrative,Section 3.3.3,the concentration of impregnation bath to obtain an appropriate dose of IBU-L,no,no,The study demonstrated the drug release kinetics of ibuprofen from the developed dressing.
10.3390/gels10100631,BioMOF@cellulose Glycerogel Scaffold with Multifold Bioactivity: Perspective in Bone Tissue Repair.,GenAI\papers\pdf\10.3390_gels10100631__1adedbb41b.pdf,text,no,primary_experiment,yes,no,no,,,both,uncertain,,yes,yes,PAGE 9,no,narrative,PAGE 9,the release profiles of ibuprofen and syringic acid in PBS at 310 K from CaSyr-1(ibu) NPs and CaSyr-1(ibu)@NCC-G glycerogel.,narrative,PAGE 4,the ibuprofen loading in the CaSyr-1(ibu) sample was estimated by 1H-NMR...,no,no,
10.3390/gels10110704,Decellularized Macroalgae as Complex Hydrophilic Structures for Skin Tissue Engineering and Drug Delivery.,GenAI\papers\pdf\10.3390_gels10110704__b52d02c892.pdf,text,yes,primary_experiment,yes,yes,no,Section 2.4: Drug Loading and In Vitro Drug Release,unknown,IVRT,both,green algae (Ulva lactuca); red algae (Rhodophyta),yes,yes,Table 1,no,table_text,Table 1 shows hydration degree and release rate constants for Ibuprofen diffusion profiles from hydrogels.,Hydration degree (HD) was significantly influenced by the agent used in the decellularization process...,table_text,"Section 2.4: Drug Loading and In Vitro Drug Release, Table 1",The drug loading capacity was associated with scaffold porosity and its components’ interaction with Ibuprofen molecules...,no,no,Study includes detailed results on both ibuprofen release profile and scaffold characteristics.
10.3390/gels11010041,Permeation Enhancer in Microemulsions and Microemulsion-Based Gels: A Comparison of Diethylene Glycol Monoethyl Ether and Oleyl Alcohol.,GenAI\papers\pdf\10.3390_gels11010041__cb148324e0.pdf,text,yes,primary_experiment,yes,yes,yes,Section 2.4.1,Section 2.4.1,IVPT,both,Strat-M® membrane and regenerated cellulose membrane,yes,yes,Table 2,no,table_text,Table 2,"Table 2 lists the flux (J), permeability coefficient (Kp), and lag time (tlag) for the formulations, indicating cumulative ibuprofen permeation over 24 hours.",table_text,Table 4,"Table 4 displays the compositions of the microemulsion formulations, detailing the percentage of each component including ibuprofen and other excipients.",no,no,The study emphasizes the comparative effectiveness of different microemulsions with ibuprofen as a model drug.
10.3390/gels11100775,"Hybrid Alginate-Based Polysaccharide Aerogels Microparticles for Drug Delivery: Preparation, Characterization, and Performance Evaluation.",GenAI\papers\pdf\10.3390_gels11100775__4fb67cd5a5.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,uncertain,N/A,yes,yes,Table 2,no,table_text,Table 2,"Table 2 shows the loading percentage of ibuprofen in selected aerogels, indicating numerical data for loading efficiency and cumulative release.",table_text,Table 2,Table 2 provides detailed loading efficiency and release data associated with different formulations.,no,no,This study provides quantitative data on ibuprofen loading and release profiles from alginate/carrageenan aerogels.
10.3390/gels8070406,In Vitro Evaluation of Smart and pH-Sensitive Chondroitin Sulfate/Sodium Polystyrene Sulfonate Hydrogels for Controlled Drug Delivery.,GenAI\papers\pdf\10.3390_gels8070406__c9e0d5d069.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,IVPT,both,chondroitin sulfate/sodium polystyrene sulfonate hydrogels,yes,yes,Table 1,no,table_text,"Table 1 contains dynamic swelling and polymer volume fraction data, showing numerical values over time for drug release.",Dynamic Swelling up to 72 h Polymer Volume Fraction pH 1.2 pH 4.6 pH 7.4,table_text,"Table 2 lists drug loading values for various formulations, providing numerical data.",Drug Loaded (mg)/500 mg of Dry Gels Weight Method Extraction Method,no,no,
10.3390/gels9090699,Self-Healing Oxalamide Organogelators of Vegetable Oil.,GenAI\papers\pdf\10.3390_gels9090699__dbc4ef75b3.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,IVPT,uncertain,unknown,yes,yes,PAGE 21,no,narrative,PAGE 21,The 0.5 wt% of 1 oil gel showed release of 80% of IB in the first 4 h...,unknown,unknown,unknown,no,yes,"The study focuses on the drug delivery objectives with ibuprofen, presenting relevant cumulative data over specified timepoints."
10.3390/ijms150814014,Silver nanoparticles/ibuprofen-loaded poly(L-lactide) fibrous membrane: anti-infection and anti-adhesion effects.,GenAI\papers\pdf\10.3390_ijms150814014__56d56e5666.pdf,figure,no,primary_experiment,yes,no,no,,,IVPT,both,poly(L-lactide) fibrous membranes,yes,yes,Figure 3B,no,figure,Figure 3B,"Figure 3B shows IBU release from Ag4%-IBU4%-PLLA electrospun fibers, indicating cumulative release behavior.",narrative,"Results section, paragraph discussing drug release",The IBU release profile of Ag4%–IBU4%–PLLA electrospun fibers is shown in Figure 3B.,no,no,Study focuses on ibuprofen-loaded fibrous membranes; endpoints and formulations are clearly defined.
10.3390/ijms242115632,Enhancing Transdermal Delivery: Investigating the Impact of Permeation Promoters on Ibuprofen Release and Penetration from Medical Patches-In Vitro Research.,GenAI\papers\pdf\10.3390_ijms242115632__cc885c7871.pdf,text,yes,primary_experiment,yes,yes,uncertain,Methods Section,Methods Section,IVPT,skin,pig skin,yes,yes,Table 6,no,table_text,Table 6,Table 6 summarizes the cumulative mass of IBU followed by an analysis of the skin permeation parameters.,table_text,Table 7,Table 7 shows the appropriate weights with which to prepare the formulation.,no,no,Study focuses on different formulations of ibuprofen in transdermal patches and analyzes their permeation through skin.
10.3390/ma10010074,Supercritical CO₂-Assisted Spray Drying of Strawberry-Like Gold-Coated Magnetite Nanocomposites in Chitosan Powders for Inhalation.,GenAI\papers\pdf\10.3390_ma10010074__5bcebc0cec.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,uncertain,uncertain,yes,yes,Table 3,no,table_text,Table 3,"Table 3 summarizes the Peppas’ Adjustment for IBP (Ibuprofen) release, showing cumulative amounts released over the specific time points.",table_text,Table 1,Table 1 details the microparticle composition and properties including mean diameter and other physical-chemical properties.,no,no,Study focuses on the release kinetics of ibuprofen from novel nanocomposite formulations.
10.3390/membranes12080762,In Situ Generation of Fouling Resistant Ag/Pd Modified PES Membranes for Treatment of Pharmaceutical Wastewater.,GenAI\papers\pdf\10.3390_membranes12080762__fa6875b6e1.pdf,text,yes,primary_experiment,yes,yes,no,Figure 2,unknown,IVRT,uncertain,PES membranes with Ag/Pd nanoparticles,yes,yes,Table 3,no,table_text,"Table 3 shows water contact angles, fluxes, porosity, zeta potential, mean pore radius, and salt rejection properties of the Ag/Pd PES membranes. The table shows numerical rejection values for ibuprofen.","The rejection of organic compounds was also investigated, with Table 3 detailing the rejection percentages for ibuprofen along with cumulative permeability data.",table_text,Table 1 conveys the composition of the PES casting solutions used for membrane fabrication.,Table 1 presents the formulations of the casting solutions including Ag/Pd concentrations for the membrane.,no,no,
10.3390/mi11060554,Novel Design Approaches in the Fabrication of Polymeric Microarray Patches via Micromoulding.,GenAI\papers\pdf\10.3390_mi11060554__69230bf446.pdf,figure,no,primary_experiment,yes,yes,yes,In vitro permeation section,In vitro permeation section,IVPT,skin,dermal porcine skin,yes,yes,Figure 4 and Results text,no,figure,Figure 4,"Figure 4 shows in vitro permeation profiles of ibuprofen sodium via hydrogel-forming microarray patches (means ± SD, n = 3).",table_text,Table 2,"Validation parameters for the developed RP-HPLC method for the detection and quantification of ibuprofen sodium (IBU) in phosphate-buffered saline (PBS, pH 7.4).",no,no,
10.3390/molecules28176198,HPLC Analysis and In Vitro and In Silico Evaluation of the Biological Activity of Polyphenolic Components Separated with Solvents of Various Polarities from <i>Helichrysum italicum</i>.,GenAI\papers\pdf\10.3390_molecules28176198__55bbd00199.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,IVPT,uncertain,unknown,yes,no,Table 2,no,table_text,Table 2,The IC50 of ibuprofen estimated as IAD was 81.50 µg/mL.,unknown,unknown,unknown,no,yes,The study examines various fractions of H. italicum and includes ibuprofen as a standard for comparison.
10.3390/molecules30030552,The Role of the Functionalization of Biomedical Fabrics on Their Ability to Adsorb and Release Drugs.,GenAI\papers\pdf\10.3390_molecules30030552__7256dc139b.pdf,text,no,primary_experiment,yes,no,no,unknown,unknown,IVPT,uncertain,cotton gauzes,yes,yes,Table 3,no,table_text,Table 3 reports kinetic constants and amounts,Kinetic constants (second-order model) for the adsorption of IB and AM (T = 20 ◦C).,table_text,Table 3,Kinetic constants (second-order model) for the adsorption of IB and AM.,no,no,Study detailing drug adsorption and release involving ibuprofen but without diffusion cell specifics.
10.3390/nano10112165,Embedding Ordered Mesoporous Carbons into Thermosensitive Hydrogels: A Cutting-Edge Strategy to Vehiculate a Cargo and Control Its Release Profile.,GenAI\papers\pdf\10.3390_nano10112165__6748e42f34.pdf,text,yes,primary_experiment,yes,yes,yes,"Section 2.6, Ibuprofen Release from Hybrid Sol-Gel Systems","Section 2.6, Ibuprofen Release from Hybrid Sol-Gel Systems",IVPT,both,"Ordered Mesoporous Carbons, Thermosensitive Hydrogels",yes,yes,"Section 3.1.2, Ibuprofen Loading into C1 and C3 Carbons",no,narrative,"Section 3.1.2, Ibuprofen Loading into C1 and C3 Carbons","""the total mass of the drug loaded C3 and C1 decreased by approximately 50% of the initial weight, in agreement with the 1:1 initial loading""",table_text,"Table 1, Compositional information and acronyms of the formulations","""Table 1. Compositional information and acronyms of the formulations designed in this work""",no,no,
10.3390/nano11071850,pH-Responsive Chitosan/Alginate Polyelectrolyte Complexes on Electrospun PLGA Nanofibers for Controlled Drug Release.,GenAI\papers\pdf\10.3390_nano11071850__a1c10dc1dc.pdf,figure,no,primary_experiment,yes,yes,no,"Page 10, section 3.2",unknown,IVPT,skin,electrospun PLGA nanofibers,yes,yes,"Page 10, Figure 7",no,figure,"Page 10, Figure 7","Figure 7 shows the drug release kinetics for IBU measured in PBS and SGF at pH 1.0, indicating cumulative amounts released over specified timepoints.",narrative,"Page 9, section 3.2.1","The highest amount of drug loaded was evaluated at different pH values, indicating the drug loading kinetics of IBU.",no,yes,Study shows clear relationship between pH responsiveness and ibuprofen release kinetics.
10.3390/pharmaceutics11100501,Injectable Thermosensitive Formulation Based on Polyurethane Hydrogel/Mesoporous Glasses for Sustained Co-Delivery of Functional Ions and Drugs.,GenAI\papers\pdf\10.3390_pharmaceutics11100501__a28c933710.pdf,text,no,primary_experiment,yes,no,no,,,uncertain,uncertain,,yes,yes,PAGE 7,no,table_text,Table 1,"Table 1 shows compositional information and acronyms of the designed sol-gel systems, including Ibuprofen concentrations.",table_text,Table 1,"Table 1 outlines the compositions and acronyms of the designed formulations, specifying the ibuprofen content.",no,no,
10.3390/pharmaceutics12020105,Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing.,GenAI\papers\pdf\10.3390_pharmaceutics12020105__15075ef150.pdf,figure,no,primary_experiment,yes,yes,no,Section 2.2.4,unknown,IVPT,uncertain,agarose gel,yes,yes,"Results section, Figure 7",no,figure,Figure 7,"Figure 7 displays the release profiles of ibuprofen sodium (IS) from various implants, showcasing the cumulative release data over time.",unknown,unknown,unknown,no,no,"This study includes ibuprofen as a model compound; however, specific formulation details do not appear to be presented in standardized tables or distinct text passages."
10.3390/pharmaceutics12020151,Evaluation of Formulation Parameters on Permeation of Ibuprofen from Topical Formulations Using Strat-M<sup>®</sup> Membrane.,GenAI\papers\pdf\10.3390_pharmaceutics12020151__701029bf55.pdf,text,yes,primary_experiment,yes,yes,no,PAGE 3,unknown,IVPT,synthetic_membrane,Strat-M® membrane,yes,yes,PAGE 1,no,table_text,"PAGE 6, Table 5",Cumulative amount of drug permeated at the end of 24 h was highest for clear gel (3% w/w ibuprofen; F6: 739.6 ± 36.1 µg/cm2)...,table_text,"PAGE 6, Table 2",Composition of ibuprofen emulgel (F5) (3% w/w) is provided in Table 2.,no,no,
10.3390/pharmaceutics12121141,Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIs.,GenAI\papers\pdf\10.3390_pharmaceutics12121141__5990fd1cdd.pdf,text,no,primary_experiment,yes,no,no,,,IVPT,uncertain,,yes,yes,Table 1,no,table_text,Table 1,"Table 1 lists the drug release rate constants for ibuprofen, indicating Q_final results.",table_text,Table 1,Table 1 provides values of encapsulation efficiency (EE) and drug loading (DL) as part of the formulation characterization.,no,no,"No diffusion cell mentioned, only HPLC methods and nanoemulsion formulation."
10.3390/pharmaceutics13111952,Polyelectrolyte-Coated Mesoporous Bioactive Glasses via Layer-by-Layer Deposition for Sustained Co-Delivery of Therapeutic Ions and Drugs.,GenAI\papers\pdf\10.3390_pharmaceutics13111952__45146cae8a.pdf,text,yes,primary_experiment,yes,yes,no,Not explicitly detailed in document,Not applicable,IVPT,both,Cu-substituted MBG nanoparticles,yes,yes,"Results section, Table 1",no,table_text,Table 2,"Table 2 shows the weight loss percentages associated with each deposited layer and ibuprofen loading, indicating the cumulative release results.",supplement,Supplementary Information,Ibuprofen was loaded into Cu_SG_CAC and Cu_SG_CIC via specific methods detailed in the supplementary material.,yes,no,Details on specific time points and measurement methods present.
10.3390/pharmaceutics16081055,Mixed Micellar Gel of Poloxamer Mixture for Improved Solubilization of Poorly Water-Soluble Ibuprofen and Use as Thermosensitive In Situ Gel.,GenAI\papers\pdf\10.3390_pharmaceutics16081055__065e618dc2.pdf,figure,no,primary_experiment,yes,yes,no,Section 2.9: In Vitro Release Study,unknown,IVPT,both,thermosensitive mixed micellar gels,yes,yes,Section 3.2: Solubilization of Ibuprofen in Single and Mixed Polymeric Micelles,no,figure,Referencing Figure 5A,Figure 5A illustrates the values of the solubility enhancement...,narrative,Section 2.9: In Vitro Release Study,The membrane-less diffusion method was employed to evaluate in vitro drug release...,no,no,This study focuses on the release and solubilization properties of ibuprofen using mixed micellar gels.
10.3390/pharmaceutics16111359,Customizable Self-Microemulsifying Rectal Suppositories by Semisolid Extrusion 3D Printing.,GenAI\papers\pdf\10.3390_pharmaceutics16111359__cad97c6f14.pdf,text,no,primary_experiment,yes,no,no,,,both,uncertain,,yes,yes,page 7,no,narrative,Results section,The average and deviation were measured (n = 6).,table_text,Table 1,Selected composition of SMEDDS according to the solubility and self-emulsifying assessment.,no,no,
10.3390/pharmaceutics2020209,A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.,GenAI\papers\pdf\10.3390_pharmaceutics2020209__1a2e9fadde.pdf,text,yes,primary_experiment,yes,yes,yes,PAGE 2,PAGE 4,IVPT,synthetic_membrane,Synthetic membranes (13 types) listed in Table 1,yes,yes,PAGE 8,no,table_text,"PAGE 8, Table 3","Table 3. Summary of average ibuprofen flux from saturated solution (n = 6), total diffusion after 6 h and the coefficient of variation (CV) for individual synthetic membranes.",table_text,"PAGE 6, Table 2",Table 2. A mass balance result (at 60 ºC) for ibuprofen saturated solution.,no,no,Study investigates ibuprofen diffusion using various synthetic membranes in Franz diffusion cells; comprehensive quantitative results provided.
10.3390/polym12071473,Design and Preparation of New Multifunctional Hydrogels Based on Chitosan/Acrylic Polymers for Drug Delivery and Wound Dressing Applications.,GenAI\papers\pdf\10.3390_polym12071473__3f2449ea80.pdf,figure,no,primary_experiment,yes,yes,no,Section 2.2.3 Drug Release Study,unknown,IVPT,synthetic_membrane,dialysis membrane,yes,yes,Figure 6,no,figure,Figure 6,The readings expressed as cumulative release were plotted versus time in order to obtain the drug release profiles...,table_text,Table 1,The table presents the hydrogels composition in terms of synthetic monomer/initiator ratio...,no,no,
10.3390/polym15040791,"Chitin-Glucan Complex Hydrogels: Physical-Chemical Characterization, Stability, In Vitro Drug Permeation, and Biological Assessment in Primary Cells.",GenAI\papers\pdf\10.3390_polym15040791__a37a825452.pdf,text,yes,primary_experiment,yes,yes,yes,2.9. In Vitro Drug Permeation Studies,2.9. In Vitro Drug Permeation Studies,IVPT,skin,Strat-M membranes,yes,yes,Table 2,no,table_text,Table 2 shows the drug loading (DL) and entrapment efficiency (EE) values for ibuprofen.,Table 2 shows that sodium ibuprofen loading led to a drug loading of 11.25 ± 2.04 mg/cm3 and an entrapment efficiency of 14.43 ± 0.88%.,table_text,Table 1 provides data on the chemical characterization and properties of the hydrogels containing ibuprofen.,"Table 1 summarizes the compressive modulus, toughness, and other properties of the Na51*4 and Na51*6 hydrogels.",no,no,
10.3390/polym16131934,Electrospun Ibuprofen-Loaded Blend PCL/PEO Fibers for Topical Drug Delivery Applications.,GenAI\papers\pdf\10.3390_polym16131934__addfe4ce83.pdf,figure,no,primary_experiment,yes,yes,uncertain,Materials and Methods: 2.5 Fiber Electrospinning,uncertain,IVPT,skin,PCL/PEO fibers,yes,yes,Results: 3.7 In Vitro Drug Release Assay,no,figure,Results: 3.7 In Vitro Drug Release Assay,Cumulative release of IBP from various PCL/PEO fibers.,table_text,Results: 3.7 In Vitro Drug Release Assay,The average viscosities of various 10 wt% blank and IBP-loaded PCL/PEO solutions are shown in Figure 1a.,no,no,
10.3390/polym16142006,Cellulose Acetate and Polycaprolactone Fibre Coatings on Medical-Grade Metal Substrates for Controlled Drug Release.,GenAI\papers\pdf\10.3390_polym16142006__02ac8ba9aa.pdf,text,yes,primary_experiment,yes,yes,no,Section 2.2.4 (Drug Release Methodology) explains drug release methodology in a simulated body fluid that could imply diffusion cell usage.,unknown,IVPT,both,"medical-grade stainless steel, cellulose acetate, polycaprolactone",yes,yes,Table 1,no,table_text,Table 1 presents the estimated drug released in SBF or water for each membrane studied.,Table 1. Estimated drug released in SBF or water for each membrane studied...,table_text,Table 1 shows the Ibu released (mg) for different membranes.,Table 1. Estimated drug released in SBF or water for each membrane studied...,no,no,The study examines the drug release behavior of Ibu embedded in polymer membranes.
10.3797/scipharm.1204-14,"Synthesis, characterization, and in vitro evaluation of new Ibuprofen polymeric prodrugs based on 2-hydroxypropyl methacrylate.",GenAI\papers\pdf\10.3797_scipharm.1204-14__6d2c010d2d.pdf,figure,no,primary_experiment,yes,yes,no,PAGE 10,uncertain,IVPT,uncertain,cellophane dialysis bags,yes,yes,PAGE 10,no,figure,PAGE 10,Fig. 6 shows the percent of ibuprofen released from polymeric carriers as a function of time at hydrochloric acid buffer (pH 1) and 37 °C.,table_text,PAGE 12,The yields of the obtained polymeric prodrugs are presented in Table 2.,no,no,The study involves ibuprofen polymeric prodrugs and evaluates their in vitro release via diffusion cell methods.
